About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Pet Cancer Therapeutics Market Size, Share & Growth Report by 2033
Pet Cancer Therapeutics Market

Pet Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Other Therapies), By Animal (Dog, Cat, Other Animals), By Applications (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, Other Applications) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55279DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pet Cancer Therapeutics Market Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    5. U.S.
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Radiation Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Targeted Therapy
          1. By Value
        6. Other Therapies
          1. By Value
      2. By Animal
        1. Introduction
          1. Animal By Value
        2. Dog
          1. By Value
        3. Cat
          1. By Value
        4. Other Animals
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Melanoma
          1. By Value
        5. Mammary and Squamous Cell Cancer
          1. By Value
        6. Other Applications
          1. By Value
    6. Canada
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    5. U.K.
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Radiation Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Targeted Therapy
          1. By Value
        6. Other Therapies
          1. By Value
      2. By Animal
        1. Introduction
          1. Animal By Value
        2. Dog
          1. By Value
        3. Cat
          1. By Value
        4. Other Animals
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Melanoma
          1. By Value
        5. Mammary and Squamous Cell Cancer
          1. By Value
        6. Other Applications
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    5. China
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Radiation Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Targeted Therapy
          1. By Value
        6. Other Therapies
          1. By Value
      2. By Animal
        1. Introduction
          1. Animal By Value
        2. Dog
          1. By Value
        3. Cat
          1. By Value
        4. Other Animals
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Melanoma
          1. By Value
        5. Mammary and Squamous Cell Cancer
          1. By Value
        6. Other Applications
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    5. UAE
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Radiation Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Targeted Therapy
          1. By Value
        6. Other Therapies
          1. By Value
      2. By Animal
        1. Introduction
          1. Animal By Value
        2. Dog
          1. By Value
        3. Cat
          1. By Value
        4. Other Animals
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Melanoma
          1. By Value
        5. Mammary and Squamous Cell Cancer
          1. By Value
        6. Other Applications
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Radiation Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Targeted Therapy
        1. By Value
      6. Other Therapies
        1. By Value
    3. By Animal
      1. Introduction
        1. Animal By Value
      2. Dog
        1. By Value
      3. Cat
        1. By Value
      4. Other Animals
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Melanoma
        1. By Value
      5. Mammary and Squamous Cell Cancer
        1. By Value
      6. Other Applications
        1. By Value
    5. Brazil
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Radiation Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Targeted Therapy
          1. By Value
        6. Other Therapies
          1. By Value
      2. By Animal
        1. Introduction
          1. Animal By Value
        2. Dog
          1. By Value
        3. Cat
          1. By Value
        4. Other Animals
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Melanoma
          1. By Value
        5. Mammary and Squamous Cell Cancer
          1. By Value
        6. Other Applications
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Pet Cancer Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. AB Science
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Boehringer Ingelheim GmbH (Merial)
    3. Vivesto AB (AdvaVet Inc.)
    4. Elanco
    5. ELIAS Animal Health
    6. Karyopharm TherapeuticsInc.
    7. Torigen Pharmaceuticals Inc.
    8. Dechra Pharmaceuticals PLC (Anivive Lifesciences)
    9. Elekta
    10. Virbac
    11. Zoetis
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Melanoma Therapeutics Market Size The global melanoma therapeutics market size was valued at USD 8.65 billion in 2023. It is projected to reach USD 19.87 billion by 2032, growing at a CAGR of 10.80% during the forecast period (2024–2032). Mela
Buy Now
Global Report
Pain Management Therapeutics Market Size The global pain management therapeutics market size was valued at USD 79.42 billion in 2023 and is projected to reach USD 115.21 billion by 2032, growing at a CAGR of 4.22% during the
Buy Now
Global Report
Peptide Therapeutics Market Size & Trends The global peptide therapeutics market size was valued at USD 45.43 billion in 2023. It is projected to reach from USD 48.11 billion in 2025 to USD 76.11 billion by 2033, growing at a CAGR
Buy Now
Global Report
Pneumonia is a prevalent form of an acute respiratory infection that affects the alveoli of the lungs. Fungi, bacteria cause the disease, or viruses mediated infection. When an individual has pneumonia, the clinical manifestations can be as severe as
Buy Now
Global Report
Market Overview The prostate cancer therapeutics market size was valued at USD 10,368 million in 2019 and is expected to grow with a CAGR of 8% during the forecast period. The prostate is a compound tubuloalveolar exocrine gland of the male reprodu
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.